Ziprasidone in Pediatric Bipolar Disorder: a 6-Week, Open-Label Comparison of Rapid vs. Slow Dose Titration.

Trial Profile

Ziprasidone in Pediatric Bipolar Disorder: a 6-Week, Open-Label Comparison of Rapid vs. Slow Dose Titration.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2014

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Bipolar disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jan 2010 Actual patient number (45) added as reported by ClinicalTrials.gov.
    • 13 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top